3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
3
Phase NA
1
Phase 3
1
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Breast Neoplasms
60
Prostatic Neoplasms
52
Squamous Cell Carcinoma of Head and Neck
43
Carcinoma, Non-Small-Cell Lung
39
Head and Neck Neoplasms
37
Lung Neoplasms
35
Lymphoma
34
Leukemia
22
Brain Neoplasms
20
Central Nervous System Neoplasms
19
Precursor Cell Lymphoblastic Leukemia-Lymphoma
18
Glioblastoma
18
Uterine Cervical Neoplasms
17
Sarcoma
17
Rectal Neoplasms
17
Lymphoma, Follicular
16
Esophageal Squamous Cell Carcinoma
16
Esophageal Neoplasms
15
Lymphoma, Large B-Cell, Diffuse
14
Hodgkin Disease
14
Burkitt Lymphoma
14
Adenocarcinoma of Lung
13
Oligodendroglioma
12
Lymphoma, Non-Hodgkin
12
Neoplasm Metastasis
11
Astrocytoma
11
Rhabdomyosarcoma
10
Lymphoma, Large-Cell, Immunoblastic
10
Neuroblastoma
9
Nasopharyngeal Carcinoma
9
Interventions
Mitomycin
12
Gemcitabine
9
BCG Vaccine
4
apaziquone
3
Epirubicin
3
erdafitinib
2
durvalumab
2
dodecyl maltoside
2
VB4-845
2
Docetaxel
2
viscum album peptide
1
valrubicin
1
pirarubicin
1
hydroxycamptothecinum
1
Transurethral Resection of Bladder
1
Therapeutic Uses
1
Standard of Care
1
Saline Solution
1
Radiotherapy
1
Polysorbates
1
Maintenance
1
Magnetic Resonance Spectroscopy
1
Injections
1
Cystoscopy
1
5-aminolevulinic acid hexyl ester
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Non-Muscle Invasive Bladder Neoplasms
×
Radiotherapy
×
Clear all
NCT07268339
2025-12-05
TRAIN
The Christie NHS Foundation Trust
Phase 3
Not yet recruiting
328 enrolled